Used in pharmaceutical research as a key intermediate in the synthesis of selective serotonin reuptake inhibitors (SSRIs). It serves as a chiral building block for developing neuroactive compounds, particularly those targeting anxiety and depression. Its structural configuration supports high receptor binding affinity, making it valuable in optimizing drug efficacy and reducing off-target effects. Also explored in the development of novel CNS agents due to its ability to cross the blood-brain barrier efficiently.